Finally, a European country has made the big decision to legalize cannabis use, possession and sales. The government of Malta announced this new law on Tuesday last week. It explained that the law had been put in place to decriminalize the use of cannabis within the country and limit the occurrence of cannabis trafficking within and around the country. Marijuana was removed from a list of the world's most dangerous drugs by the United Nations in December 2020, and several countries are now taking a more liberal stance.
Now we’ve got a bunch of teens, with a possible serial killer eating mushrooms on a Friday night in Little Caesars during a busy shift. At this point, the story was almost complete. It felt like Shane could have been a perfect victim of Dexter Morgan or something similar, perhaps making the audience ask – “how does one get to become like Shane”.
Mike Gladstone, global president and general manager of Pfizer Inflammation and Immunology unit, said that the acquisition of Arena is in line with the company's capabilities and expertise in immunology and inflammatory-related conditions. Over the years, Pfizer has successfully created an innovation engine that develops potential medicines for patients worldwide with chronic and debilitating immuno-inflammatory conditions. The company understands that there is an urgent need to look into other treatment options with high potential, which is where Arena's cannabinoid-drug pipeline comes in.
There are also other important findings in the study, such as stress relief and relaxation being the top reasons people use cannabis. In addition, 52% of users turn to cannabis to help their mental health during the pandemic. More people today are seeing the benefits of combining cannabis with exercise, which challenges the previous stereotypes of unhealthy and lazy cannabis users. With that, 13% of consumers say that they regularly use cannabis prior to exercise, which they say improves their training.
(December 13, 2021) Two pharmaceutical companies have issued recalls in December due to manufacturing issues that may impact the safety and quality of their drug products.
Edge Pharma issued a voluntary recall for all drug products produced in its FDA-registered 503B outsourcing facility in Colchester, VT. Edge stated that products were removed as a result of “process issues” that may have impacted the sterility of its drug products. The recall includes a wide variety of sterile products. These include lidocaine, vancomycin, norepinephrine, and methotrexate, as well as a number of non-sterile products. The use of non-sterile drug products that are intended to be sterile may result in serious, possibly fatal, infections.
Also this month, Teligent, Inc. issued a voluntary worldwide recall on two lots of their topical lidocaine solution due to superpotency. The two lots had been distributed throughout the United States. Superpotent lidocaine can be dangerous to patients and has the potential to cause systemic toxicity leading to hypotension, brachycardia, and possible cardiovascular collapse. In October, the New Jersey company issued a similar recall in connection with five lots of topical lidocaine solution.
Fortunately, no adverse events related to the December recalls by either Edge or Teligent have been reported.
Reading Time: 3minutes by guest columnist Dr David Koepsell It has been seven years since the US Supreme Court finally weighed in on the issue of gene patents, invalidating the practice so companies could no longer patent unaltered parts of nature. That was a great step in the right direction. But that ruling […]
Despite the recent progress being made with respect to the regulations of digital currencies in India, a Lok Sabha lawmaker, Nishikant Dubey, advocated that...
LINKÖPING, Sweden, Dec. 2, 2021 /PRNewswire/ -- AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device...
Sensus to Bring FDA-cleared Non-invasive Drug-delivery System and Treatment Alternative to Needles to Dermatologists Beginning BOCA RATON, Fla, Dec. 01, 2021 (GLOBE...